Drug intelligence / Profile preview

N-(2-(((5-chloro-2-pyridinyl)amino)sulfonyl)phenyl)-4-(2-oxo-1(2H)-pyridinyl)benzamide

Development stage
Unknown
Modality
Small Molecules
01

Overview

This compound is a synthetic small molecule with the molecular formula C23H17ClN4O4S and a molecular weight of approximately 480.92 g/mol[1][4]. It belongs to the class of benzanilides, specifically anilide derivatives containing sulfonamide and pyridine moieties[6]. The IUPAC name is N-{2-[ (5-chloropyridin‑2‑yl )sulfamoyl ]phenyl }‑4‑( 2‑oxo‑1,​ ​dihydropyridin-​ ​1-​ ​y l )benzamide[1][6]. There are no known approved medical indications or clinical trials associated with this compound as of June 2025, and it appears to be primarily used in research settings as an experimental chemical probe or tool compound[5].

Other names
N-{2-[(5-chloropyridin-2-yl)sulfamoyl]phenyl}-4-(2-oxo-1,2-dihydropyridin-1-yl)benzamideN-{2-[[(5-chloro-pyridin - 3.0.0.0.0.0.0.0 - yl)sulfamoyl]phenyl}-4-(2- oxo- 1( 3. . . (truncated for clarity; see ChemSpider and DrugBank for full list)[4][6]

Beyond the preview

Go deeper on N-(2-(((5-chloro-2-pyridinyl)amino)sulfonyl)phenyl)-4-(2-oxo-1(2H)-pyridinyl)benzamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-(2-(((5-chloro-2-pyridinyl)amino)sulfonyl)phenyl)-4-(2-oxo-1(2H)-pyridinyl)benzamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call